NasdaqGS:XRAYMedical Equipment
Dentsply Sirona (XRAY): Assessing Valuation Following Quarterly Miss, Impairment Charge, and Leadership Changes
Dentsply Sirona (XRAY) shares drew extra attention after the company’s third-quarter results missed expectations. Net sales fell, losses persisted, and a $263 million impairment charge highlighted ongoing challenges. Softer demand and tariffs also weighed on U.S. performance.
See our latest analysis for DENTSPLY SIRONA.
With sales declining, a significant impairment charge, and a change in the CFO seat all in the mix this quarter, Dentsply Sirona’s share price has lost momentum, posting a...